ATLANTA, April 25, 2012 /PRNewswire/ – New post-hoc analyses of pivotal clinical trials of Neupro® (rotigotine transdermal system) in patients with Restless Legs Syndrome (RLS)/Willis Ekbom disease analysed …
Continue reading here:First assessment of individual RLS domains in new post-hoc analyses of Neupro® studies

